Neuromersiv brings together an experienced founding team and group of leading subject matter experts as advisors to provide their wealth of knowledge, skills and support for the next-generation in neurorehabilitation. The combination of each individual’s proven success in the fields of clinical practice, cutting-edge technology, research and business commercialisation provides Neuromersiv with a unique advantage.
Co-Founder & CEO
Anshul has over 10 years experience in leading large technical teams in creating leading edge Hollywood content and software, including being a part of the Academy Award winning team to work on blockbuster film, Happy Feet.
Co-Founder & COO
Oliver has 7 years experience in design and project management having run
visual effects & VR production studio, pic4 over this time. Prior to this, Oliver served as a digital media producer and designer for global children’s entertainment brand, The Wiggles.
Commercialisation & Strategy
Warren is the General Manager of Cicada MedLab and the founder and Executive Chairman of MedTech International. As part of the global executive team to introduce PillCam® to the world, he was instrumental in the company going from startup in 2000 to being sold in 2014 for $1 billion.
Professor Michael Nilsson MD PhD FAFRM (RACP)
Michael is the Director of the Centre for Rehab Innovations and Global Innovation Chair of Rehabilitation Medicine at the University of Newcastle. As a senior translational researcher, clinician and leader in Rehabilitation Medicine, he recently established CRI together with an interdisciplinary team of leading researchers and clinicians. CRI engages with industry and public and private healthcare to develop technology-supported solutions for individually-tailored health and rehabilitation programs.
Dr Jodie Marquez PhD
Clinical & Research
Jodie is a physiotherapist with 20 years of experience in neuro-rehabilitation. She currently serves as Senior Lecturer at the University of Newcastle and has served as Chief Investigator on a number of funded clinical trial studies.
After surviving a severe stroke at 22 years of age, Stephanie has committed her life to improve the healthcare system and easing the burden for other survivors. She currently serves as an Executive Board Member for NSW Agency for Clinical Innovation and is a regular keynote speaker on the topic of stroke and the impact of rehabilitation from a consumer perspective. Stephanie was awarded for her work in 2019 by the National Stroke Foundation.